Pal, R., Deb, I., Sarzynska, J
The heart rate increase is likely due to direct stimulation of GLP-1 and glucagon receptors in the heart, while the blood pressure reduction may be caused by other systemic effects like vasodilation and increased sodium excretion from the kidneys
When GHRP-6 is paired with a GHRH analog, research-use discussions usually place both injections in the same dosing window, often at similar microgram amounts
Glucagon-like peptide 1 (GLP-1) weight loss medications have helped many people lose weight, but they dont work for everyone
Other concerns include hypoglycemia, particularly when GLP-1 RA are used in combination with insulin or sulfonylureas, as well as potential CV effects [73]
The number on the scale starts to drop